摘要
目的 :综述早产治疗的新进展。方法 :检索大量国内外文献 ,综合归纳。结果 :一种抑制宫缩的新药———催产素受体拮抗剂依保(atosiban)是一种有效的、副反应较少的、具有广泛临床应用前景的治疗早产的药物。结论 :Atosiban是一种值得产科医生期待的治疗早产的新药。
Preterm birth is one of common complications,and is major cause of perinatal mortality and morbidity in obstetric.The recent introduction of the oxytocin antagonist,atosiban,represents a new Effective and safe drug of the uterotonic antagonist in treatment of preterm birth.The aim of this review is to discuss the reasons of preterm labor and development in treatment of preterm birth.
出处
《大理学院学报(综合版)》
CAS
2004年第5期95-97,共3页
Journal of Dali University